Day: February 5, 2020

Renforth Resumes Drilling at New Alger

MotherlodeTV
RFR.C, Renforth Resources, gold, Quebec

Renforth Resources Inc. (CSE:RFR)(OTC Pink:RFHRF) (“Renforth” or the “Company”) is pleased to announce that drilling has resumed on Renforth’s wholly owned New Alger gold property, located in the Cadillac Mining Camp in northwestern Quebec. This program will drill several longer holes across the Cadillac Break, through the Piché volcanics and into the Pontiac sediments, further exploring the first, where Renforth recently discovered new gold occurrences, and getting deeper pierce points within the Piché, which hosts the existing identified mineralization on the property. The Company is pleased to have the support of shareholders in funding the Company in December 2019, those funds are being used to increase our knowledge and the value of New Alger. read more

Golden Predator and Yukon Government Announce Project Coordination Committee Struck for Brewery Creek Mine

This is a joint news release with Yukon Government
MotherlodeTV
Golden Predator, V.GPY, gold, Yukon, Bill Sheriff

Golden Predator Mining Corp. (TSX.V:GPY, OTCQX:NTGSF) (the “Company”) announces the Government of Yukon and Golden Predator Mining Corp. established a project coordination committee pertaining to the Brewery Creek Mine, effective January 6, 2020. The committee had its first meeting during the Mineral Exploration Roundup Mining Conference in Vancouver, British Columbia, last month. The committee will enhance communications with respect to the development and production plans for the Brewery Creek project located near Dawson City, Yukon. read more

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

MotherlodeTV
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, accompanied by FSD Pharma Biosciences leadership, will be participating in the 22nd Annual BIO CEO & Investor conference, including presenting a company overview at 9:45 a.m. ET on Monday, February 10, 2020. read more